Quarterly Results

DR AGARWALS EYE HOSPITAL LTD.

NSE : NABSE : 526783ISIN CODE : INE934C01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE3103.40-7.05 (-0.23 %)
PREV CLOSE ( ) 3110.45
OPEN PRICE ( ) 3101.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 821
TODAY'S LOW / HIGH ( )3100.00 3149.10
52 WK LOW / HIGH ( ) 886.83550
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
756.7
832.7
778
692.1
Total Expenditure
551.8
608.8
559
482.9
PBIDT (Excl OI)
204.9
223.9
219
209.2
Other Income
9.5
22.9
11.1
6.1
Operating Profit
214.4
246.8
230.1
215.3
Interest
18.3
16.9
16.2
18.1
Exceptional Items
NA
NA
NA
NA
PBDT
196.1
229.9
213.9
197.2
Depreciation
68.9
63.4
58.5
15.4
Profit Before Tax
127.2
166.5
155.4
181.8
Tax
32.8
40.6
40
45
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
94.40
125.9
115.4
136.8
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
94.40
125.9
115.4
136.8
Equity Capital
47
47
47
47
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
20.08
26.78
24.55
29.10
Calculated EPS (Annualised)
80.34
107.14
98.21
116.42
No of Public Share Holdings
1320829
1320829
1320829
1320829
% of Public Share Holdings
28.1
28.1
28.1
28.1
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
27.07
26.88
28.14
30.22
PBIDTM%
28.33
29.63
29.57
31.10
PBDTM%
25.91
27.60
27.49
28.49
PBTM%
16.80
19.99
19.97
26.26
PATM%
12.47
15.11
14.83
19.76
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.